[1] Demopoulos RI, Aronov R, Mesia A. Clues to the pathogenesis of fallopian tube carcinoma:a morphological and immunohistochemical case control study[J]. Int J Gynecol Pathol, 2001, 20(2):128-132. [2] Lin HW, Tu YY, Lin SY, et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study[J]. Lancet Oncol, 2011, 12(9):900-904. [3] Hunn J, Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology[J]. Clin Obstet Gynecol,2012,55(1):3-23. [4] Riska A, Finne P, Alfthan H, et al. Past chlamydial infection is not associated with primary fallopian tube carcinoma[J]. Eur J Cancer, 2006, 42(12):1835-1838. [5] Riska A, Finne P, Koskela P, et al. Human papillomavirus infection and primary fallopian tube carcinoma: a seroepidemiological study[J]. BJOG, 2007, 114(4):425-429. [6] Gungor T, Keskin HL, Zergeroglu S, et al. Tuberculous salpingitis in two of five primary fallopian tube carcinomas[J]. J Obstet Gynaecol, 2003, 23(2):193-195. [7] Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation[J]. JAMA, 2006, 296(2):185-192. [8] Rebbeck TR, Kauff ND, Domchek SM, et al. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers[J]. J Natl Cancer Inst, 2009, 101(2):80-87. [9] Domchek SM, Friebel TM, Singer CF, et a1. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality[J]. JAMA, 2010, 304(9):967-975. [10] Schmeler KM, Lynch HT, Chen LM, et al.Prophylactic surgery to reduce the risk of gynecology cancers in the Lynch syndrome[J].N End J Med, 2006, 354:261-269. [11] Salvador S, Gilks B, Kbel M, et al. The fallopian tube: primary site of most pelvic high-grade serous carcinomas[J]. Int J Gynecol Cancer, 2009, 19(1):58-64. [12] Kwon JS, Tinker A, Pansegrau G, et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers[J]. Obstet Gynecol, 2013, 121(1):14-24. [13] Leblanc E. Radical fimbriectomy for young BRCA mutation carriers at risk of pelvic serous carcinoma[EB/OL]. 2012. ClinicalTrialsgov. Available at: http://clinicaltrials.gov/ct2/show /NCT 01608074. Retrieved July 10, 2012. [14] Sandoval C, Fung-Kee-Fung M, Gilks B, et al. Examining the use of salpingectomy with hysterectomy in Canada[J].Curr Oncol,2013,20:173-175. |